107 related articles for article (PubMed ID: 26424413)
1. p53 Mutants Access Epigenetic Pathways to Promote Tumor Growth.
Cancer Discov; 2015 Nov; 5(11):OF2. PubMed ID: 26424413
[TBL] [Abstract][Full Text] [Related]
2. Induction of genetic instability by gain-of-function p53 cancer mutants.
Xu Y
Oncogene; 2008 Jun; 27(25):3501-7. PubMed ID: 18223686
[TBL] [Abstract][Full Text] [Related]
3. P53 tumor suppression network in cancer epigenetics.
Mishra A; Brat DJ; Verma M
Methods Mol Biol; 2015; 1238():597-605. PubMed ID: 25421682
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific adenoviral gene therapy: transcriptional repression of gene expression by utilizing p53-signal transduction pathways.
Kühnel F; Zender L; Wirth T; Schulte B; Trautwein C; Manns M; Kubicka S
Cancer Gene Ther; 2004 Jan; 11(1):28-40. PubMed ID: 14681724
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations promote proteasomal activity.
Oren M; Kotler E
Nat Cell Biol; 2016 Jul; 18(8):833-5. PubMed ID: 27463250
[TBL] [Abstract][Full Text] [Related]
6. Regulation of p53 by ING family members in suppression of tumor initiation and progression.
Jafarnejad SM; Li G
Cancer Metastasis Rev; 2012 Jun; 31(1-2):55-73. PubMed ID: 22095030
[TBL] [Abstract][Full Text] [Related]
7. Dissecting p53 tumor suppressor function in vivo through the analysis of genetically modified mice.
Johnson TM; Attardi LD
Cell Death Differ; 2006 Jun; 13(6):902-8. PubMed ID: 16557272
[No Abstract] [Full Text] [Related]
8. Keep-ING balance: tumor suppression by epigenetic regulation.
Tallen G; Riabowol K
FEBS Lett; 2014 Aug; 588(16):2728-42. PubMed ID: 24632289
[TBL] [Abstract][Full Text] [Related]
9. The maintenance of epigenetic states by p53: the guardian of the epigenome.
Levine AJ; Greenbaum B
Oncotarget; 2012 Dec; 3(12):1503-4. PubMed ID: 23237909
[No Abstract] [Full Text] [Related]
10. The tumor suppressor protein p53: a receptor to genotoxic stress that controls cell growth and survival.
Hainaut P
Curr Opin Oncol; 1995 Jan; 7(1):76-82. PubMed ID: 7696367
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes in cancer.
Iacobuzio-Donahue CA
Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of p53 protein in human tumors.
Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
[TBL] [Abstract][Full Text] [Related]
13. Transcription regulation by mutant p53.
Weisz L; Oren M; Rotter V
Oncogene; 2007 Apr; 26(15):2202-11. PubMed ID: 17401429
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of the human p53 gene promoter by the CTCF transcription factor in transformed cell lines.
Soto-Reyes E; Recillas-Targa F
Oncogene; 2010 Apr; 29(15):2217-27. PubMed ID: 20101205
[TBL] [Abstract][Full Text] [Related]
15. Role of Stat3 in regulating p53 expression and function.
Niu G; Wright KL; Ma Y; Wright GM; Huang M; Irby R; Briggs J; Karras J; Cress WD; Pardoll D; Jove R; Chen J; Yu H
Mol Cell Biol; 2005 Sep; 25(17):7432-40. PubMed ID: 16107692
[TBL] [Abstract][Full Text] [Related]
16. Cancer: an epigenetic landscape.
Dhanasekaran K; Arif M; Kundu TK
Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
[No Abstract] [Full Text] [Related]
17. p53 Isoform Delta113p53 in zebrafish.
Chen J; Peng J
Zebrafish; 2009 Dec; 6(4):389-95. PubMed ID: 19916829
[TBL] [Abstract][Full Text] [Related]
18. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
19. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
[TBL] [Abstract][Full Text] [Related]
20. [Cancer mutations and normal cell regulation].
Fredholm BB
Lakartidningen; 1992 Oct; 89(43):3568, 3571-2. PubMed ID: 1460965
[No Abstract] [Full Text] [Related]
[Next] [New Search]
